Your browser doesn't support javascript.
loading
The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study.
Omrani, Ali S; Almaslamani, Muna A; Daghfal, Joanne; Alattar, Rand A; Elgara, Mohamed; Shaar, Shahd H; Ibrahim, Tawheeda B H; Zaqout, Ahmed; Bakdach, Dana; Akkari, Abdelrauof M; Baiou, Anas; Alhariri, Bassem; Elajez, Reem; Husain, Ahmed A M; Badawi, Mohamed N; Abid, Fatma Ben; Abu Jarir, Sulieman H; Abdalla, Shiema; Kaleeckal, Anvar; Choda, Kris; Chinta, Venkateswara R; Sherbash, Mohamed A; Al-Ismail, Khalil; Abukhattab, Mohammed; Ait Hssain, Ali; Coyle, Peter V; Bertollini, Roberto; Frenneaux, Michael P; Alkhal, Abdullatif; Al-Kuwari, Hanan M.
Afiliación
  • Omrani AS; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050. aomrani@hamad.qa.
  • Almaslamani MA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Daghfal J; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alattar RA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Elgara M; Medical Education Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Shaar SH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Ibrahim TBH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Zaqout A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Bakdach D; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Akkari AM; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Baiou A; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alhariri B; Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Elajez R; Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Husain AAM; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Badawi MN; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abid FB; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abu Jarir SH; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abdalla S; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Kaleeckal A; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Choda K; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Chinta VR; Business Intelligence Unit, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Sherbash MA; Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Al-Ismail K; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Abukhattab M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Ait Hssain A; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Coyle PV; Division of Virology, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Bertollini R; Ministry of Public Health, Doha, Qatar, PO Box 42.
  • Frenneaux MP; Scientific, Academic and Faculty Affairs, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Alkhal A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar, PO Box 3050.
  • Al-Kuwari HM; Ministry of Public Health, Doha, Qatar, PO Box 42.
BMC Infect Dis ; 20(1): 777, 2020 Oct 19.
Article en En | MEDLINE | ID: mdl-33076848
BACKGROUND: There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19, and to identify risk factors associated with admission to an intensive care unit (ICU). METHODS: This was a retrospective cohort study including the first consecutive 5000 patients with COVID-19 in Qatar who completed 60 days of follow up by June 17, 2020. The primary outcome was all-cause mortality at 60 days after COVID-19 diagnosis. In addition, we explored risk factors for admission to ICU. RESULTS: Included patients were diagnosed with COVID-19 between February 28 and April 17, 2020. The majority (4436, 88.7%) were males and the median age was 35 years [interquartile range (IQR) 28-43]. By 60 days after COVID-19 diagnosis, 14 patients (0.28%) had died, 10 (0.2%) were still in hospital, and two (0.04%) were still in ICU. Fatal COVID-19 cases had a median age of 59.5 years (IQR 55.8-68), and were mostly males (13, 92.9%). All included pregnant women (26, 0.5%), children (131, 2.6%), and healthcare workers (135, 2.7%) were alive and not hospitalized at the end of follow up. A total of 1424 patients (28.5%) required hospitalization, out of which 108 (7.6%) were admitted to ICU. Most frequent co-morbidities in hospitalized adults were diabetes (23.2%), and hypertension (20.7%). Multivariable logistic regression showed that older age [adjusted odds ratio (aOR) 1.041, 95% confidence interval (CI) 1.022-1.061 per year increase; P < 0.001], male sex (aOR 4.375, 95% CI 1.964-9.744; P < 0.001), diabetes (aOR 1.698, 95% CI 1.050-2.746; P 0.031), chronic kidney disease (aOR 3.590, 95% CI 1.596-8.079, P 0.002), and higher BMI (aOR 1.067, 95% CI 1.027-1.108 per unit increase; P 0.001), were all independently associated with increased risk of ICU admission. CONCLUSIONS: In a relatively younger national cohort with a low co-morbidity burden, COVID-19 was associated with low all-cause mortality. Independent risk factors for ICU admission included older age, male sex, higher BMI, and co-existing diabetes or chronic kidney disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Pregnancy País/Región como asunto: Asia Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Pregnancy País/Región como asunto: Asia Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido